{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:05:29Z","timestamp":1791216329173,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10120-025-01629-3","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T09:53:00Z","timestamp":1750067580000},"page":"749-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Positive association between anti-Helicobacter pylori IgG antibody titers and atrophic gastritis in a Latvian cohort"],"prefix":"10.1007","volume":"28","author":[{"given":"Joo Hyun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inese","family":"Po\u013caka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danute","family":"Ra\u017euka-Ebela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Bogdanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Parshutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-8855","authenticated-orcid":false,"given":"M\u0101rcis","family":"Leja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-5099","authenticated-orcid":false,"given":"Jin Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"1629_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cnacers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1629_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000506509","volume":"38","author":"P Petryszyn","year":"2020","unstructured":"Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric cancer: where are we heading? Dig Dis. 2020;38:280\u20135.","journal-title":"Dig Dis"},{"key":"1629_CR3","first-page":"177","volume-title":"Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of the IARC working group on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer (IARC)","year":"1994","unstructured":"International Agency for Research on Cancer (IARC). Working Group on the Evaluation of Carcinogenic Risks to Humans Helicobacter pylori. In: Schistosomes, liver flukes and Helicobacter pylori: views and expert opinions of the IARC working group on the evaluation of carcinogenic risks to humans. Lyon, France: IARC; 1994. p. 177\u2013240."},{"key":"1629_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784\u20139.","journal-title":"N Engl J Med"},{"key":"1629_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2036.2004.02075.x","volume":"20","author":"G Nardone","year":"2004","unstructured":"Nardone G, Rocco A, Malfertheiner P. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther. 2004;20:261\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"1629_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ijc.28344","volume":"134","author":"A Sadjadi","year":"2014","unstructured":"Sadjadi A, Derakhshan MH, Yazdanbod A, Boreiri M, Paraeian M, Babaei M, et al. Neglected role of hookah and opium in gastric carcinogenesis: a cohort study on risk factors and attributable fractions. Int J Cancer. 2014;134:181\u20138.","journal-title":"Int J Cancer"},{"key":"1629_CR7","first-page":"689","volume":"19","author":"R Ladeiras-Lopes","year":"2008","unstructured":"Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689\u2013701.","journal-title":"Cancer Causes Control"},{"key":"1629_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.12659\/MSM.899423","volume":"23","author":"K Ma","year":"2017","unstructured":"Ma K, Baloch Z, He TT, Xia X. Alcohol consumption and gastric cancer risk: a meta-analysis. Med Sci Monit. 2017;23:238\u201346.","journal-title":"Med Sci Monit"},{"key":"1629_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1349-7006.2003.tb01353.x","volume":"94","author":"M Tatemichi","year":"2003","unstructured":"Tatemichi M, Hanada GS, Nishimoto IN, Kowalski LP, Iriya K, Rodriques JJ, Tsugane S. Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci. 2003;94:64\u20139.","journal-title":"Cancer Sci"},{"key":"1629_CR10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/1055-9965.EPI-06-1048","volume":"16","author":"G Suzuki","year":"2007","unstructured":"Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, et al. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev. 2007;16:1224\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1629_CR11","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/ijc.27514","volume":"131","author":"M Watanabe","year":"2012","unstructured":"Watanabe M, Kato J, Inoue I, Yoshimura N, Yoshida T, Mukoubayashi C, et al. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer. 2012;131:2632\u201342.","journal-title":"Int J Cancer"},{"key":"1629_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1158\/1055-9965.EPI-19-0993","volume":"29","author":"M Inoue","year":"2020","unstructured":"Inoue M, Sawada N, Goto A, Shimazu T, Yamaji T, Iwasaki M, et al. High-negative anti-Helicobacter pylori IgG antibody titers and long-term risk of gastric cancer: results from a large-scale population-based cohort study in Japan. Cancer Epidemiol Biomarkers Prev. 2020;29:420\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"1629_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cgh.2024.02.023","volume":"22","author":"DT M\u00fclder","year":"2024","unstructured":"M\u00fclder DT, Hahn AI, Huang RJ, Zhou MJ, Blake B, Omofuma O, et al. Prevalence of gastric precursor lesions in countries with differentiated gastric cancer burden: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024;22(8):1605\u201317.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1629_CR14","first-page":"1094","volume":"90","author":"ETH Fontham","year":"1995","unstructured":"Fontham ETH, Ruiz B, Perez A, Hunter F, Correa P. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol. 1995;90:1094\u2013101.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1629_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0016-5085(91)90474-Y","volume":"101","author":"WE Karnes Jr","year":"1991","unstructured":"Karnes WE Jr, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, Walsh JH. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterol. 1991;101(1):167\u201374.","journal-title":"Gastroenterol"},{"key":"1629_CR16","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3390\/diagnostics12071746","volume":"12","author":"C Robles","year":"2022","unstructured":"Robles C, Rudzite D, Polaka I, Sjomina O, Tzivian L, Kikuste I, et al. Assessment of serum pepsinogen with Gastrin-17 in gastric cancer risk assessment-results from the GISTAR Pilot study. Diagnostics. 2022;12:1746.","journal-title":"Diagnostics"},{"key":"1629_CR17","volume":"1","author":"JY Park","year":"2019","unstructured":"Park JY, Polaka I, Parshutin S, Kikuste I, Isajevs S, Santare D, et al. Trial Profile: pilot study of the multicentre randomized trial of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (the GISTAR Pilot study). Microb Health Dis. 2019;1: e165.","journal-title":"Microb Health Dis."},{"key":"1629_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016999","volume":"7","author":"M Leja","year":"2017","unstructured":"Leja M, Park JY, Murillo R, Liepniece-Karele I, Isajevs S, Kikuste I, et al. Multicentric randomized study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study. BMJ Open. 2017;7: e016999.","journal-title":"BMJ Open"},{"key":"1629_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12393","author":"M Leja","year":"2017","unstructured":"Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, et al. Detection of gastric atrophy by circulating pepsinogens: a comparison of three assays. Helicobacter. 2017. https:\/\/doi.org\/10.1111\/hel.12393.","journal-title":"Helicobacter"},{"key":"1629_CR20","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161\u201381.","journal-title":"Am J Surg Pathol"},{"key":"1629_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.dld.2008.02.030","volume":"40","author":"M Rugge","year":"2008","unstructured":"Rugge M, Correa P, Mario FD, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40:650\u20138.","journal-title":"Dig Liver Dis"},{"key":"1629_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2183\/pjab.87.405","volume":"87","author":"K Miki","year":"2011","unstructured":"Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels \u2013 \u201cABC method.\u201d Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:405\u201314.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"3","key":"1629_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/00365521.2013.869352","volume":"49","author":"H Tu","year":"2014","unstructured":"Tu H, Sun L, Dong Z, et al. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. Scand J Gastroenterol. 2014;49(3):259\u201366.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1629_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.diagmicrobio.2014.09.009","volume":"80","author":"Y Gong","year":"2014","unstructured":"Gong Y, Wei W, Yuan Y. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test. Diagn Microbiol Infect Dis. 2014;80(4):316\u201320.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"1629_CR25","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1086\/343808","volume":"186","author":"AM Nomura","year":"2002","unstructured":"Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infec Dis. 2002;186(8):1138\u201344.","journal-title":"J Infec Dis"},{"issue":"3","key":"1629_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/02841860701843035","volume":"47","author":"M Tatemichi","year":"2008","unstructured":"Tatemichi M, Sasazuki S, Inoue M, Tsugane S, Japan Public Health Center Study Group. Different etiological role of Helicobacter pylori infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol. 2008;47(3):360\u20135.","journal-title":"Acta Oncol."},{"key":"1629_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1523-5378.2009.00681.x","volume":"14","author":"M Tatemichi","year":"2009","unstructured":"Tatemichi M, Sasazuki S, Inoue M, Tsugane S, Japan Public Health Center Study Group. Clinical significance of IgG antibody titer against Helicobacter pylori. Helicobacter. 2009;14:231\u20136.","journal-title":"Helicobacter."},{"key":"1629_CR28","first-page":"10","volume":"13","author":"JH Lim","year":"2025","unstructured":"Lim JH, Han A, Cho SJ, Hahn S, Kim SG. Nomogram prediction for gastric cancer development. Clin Transl Gastroenterol. 2025;13:10.","journal-title":"Clin Transl Gastroenterol"},{"key":"1629_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/hel.12112","volume":"19","author":"JH Nam","year":"2014","unstructured":"Nam JH, Choi IJ, Kook MC, Lee JY, Cho SJ, Nam SY, Kim CG. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Hellicobacter. 2014;19:81\u20139.","journal-title":"Hellicobacter"},{"issue":"6","key":"1629_CR30","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ijc.28470","volume":"134","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Kato J, Inoue I, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134(6):1445\u201357.","journal-title":"Int J Cancer"},{"issue":"7","key":"1629_CR31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1023\/A:1018833819860","volume":"42","author":"Y Watanabe","year":"1997","unstructured":"Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case\u2013control study in a rural area of Japan. Dig Dis Sci. 1997;42(7):1383\u20137.","journal-title":"Dig Dis Sci"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01629-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:12:07Z","timestamp":1781568727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01629-3","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1996 and later versions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}